In a significant move to strengthen the pharmaceutical supply chain, regulatory authorities have proposed a mandatory installation of **Closed-Circuit Television (CCTV)** cameras in medical stores across the country. This initiative is designed to increase surveillance over the distribution of restricted medications, specifically those categorized under **Schedule H**, **Schedule H1**, and **Schedule X** of the **Drugs and Cosmetics Rules**.
The primary objective of this regulatory tightening is to curb the illegal sale and diversion of habit-forming substances. These drug categories include a wide range of potent **antibiotics**, **sedatives**, **analgesics**, and **psychotropic substances** that are strictly intended for sale only against a valid prescription from a registered medical practitioner. By mandating real-time monitoring through digital surveillance, the government aims to ensure that pharmacists adhere strictly to documentation protocols and refrain from over-the-counter sales of controlled substances.
Health experts emphasize that the illicit trade of **Schedule H1** and **Schedule X** drugs has long been a challenge for public health, contributing significantly to rising cases of chemical dependency and the growing threat of **antimicrobial resistance (AMR)**. Unauthorized access to high-strength **antibiotics** without clinical oversight accelerates the development of drug-resistant pathogens, posing a global health crisis.
Under the proposed framework, pharmacies will be required to maintain video footage for a specified duration, providing regulatory inspectors with a digital audit trail. This move aligns with broader efforts to digitize the pharmaceutical retail landscape and improve transparency. Industry stakeholders are currently evaluating the infrastructural requirements, as the mandate will require all retail outlets to maintain adequate storage for recorded data and ensure system uptime to meet compliance standards.
This proposal is expected to act as a significant deterrent against the unauthorized dispensing of life-altering medications. If implemented, it will mark a shift toward a more proactive regulatory environment where digital accountability is prioritized. Authorities are likely to utilize this surveillance data to identify patterns of irregular sales and conduct targeted inspections of outlets identified as high-risk.
Ultimately, this regulatory shift underscores a commitment to patient safety and the ethical distribution of controlled medicines. By bridging the gap between physical retail operations and digital accountability, the government intends to create a more resilient health architecture, protecting citizens from the risks associated with the misuse of potent pharmacological agents.
